DRUG · Mapped RxNorm record
Arformoterol
Normalized identity: arformoterolView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
NCT00909779
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSafety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
ArformoterolDRUG · verified · RxNorm: arformoterol
PlaceboDRUG
Sponsors & collaborators
Sumitomo Pharma America, Inc.lead sponsor
Mapped research locations
RichmondVirginia, United States3HoustonTexas, United States2San AntonioTexas, United States2BirminghamAlabama, United States2RochesterNew York, United States2GreenvilleSouth Carolina, United States2KnoxvilleTennessee, United States2ClearwaterFlorida, United States2New YorkNew York, United States1PhiladelphiaPennsylvania, United States1St LouisMissouri, United States1CincinnatiOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00909779 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.